Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy

Pancreatic adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths among men and women, being responsible for 6% of all cancer-related deaths. Surgical resection offers the only chance of cure, but only 15 to 20 percent of cases are potentially resectable at presentation. In recent years,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bittoni, Alessandro, Santoni, Matteo, Lanese, Andrea, Pellei, Chiara, Andrikou, Kalliopi, Stefano, Cascinu
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2014
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4101999/
https://ncbi.nlm.nih.gov/pubmed/25101123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/183852
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares